Pfizer reports patient death in early-stage Duchenne gene therapy trial, halts enrollment
Pfizer reports patient death in early-stage Duchenne gene therapy trial, [...]
Abandoned by Amgen, Cytokinetics lands deal for Chinese rights to heart failure prospect
Abandoned by Amgen, Cytokinetics lands deal for Chinese rights to [...]
Abandoned by Amgen, Cytokinetics lands $50M upfront deal for Chinese rights to heart failure prospect
Abandoned by Amgen, Cytokinetics lands $50M upfront deal for Chinese [...]
Sanofi gambles $1B upfront on preclinical oncology biotech, bagging Amunix for its pipeline of T-cell engagers
Sanofi gambles $1B upfront on preclinical oncology biotech, bagging Amunix [...]
Chutes & Ladders—CRISPR Therapeutics bids adieu to R&D head in securities filing
Chutes & Ladders—CRISPR Therapeutics bids adieu to R&D head in [...]
The Alzheimer’s debate may not seem positive, but AC Immune’s CEO promises it’s been a breakthrough year
The Alzheimer’s debate may not seem positive, but AC Immune’s [...]
No data, no problem. Senti will go public in $296M SPAC deal before hitting the clinic
No data, no problem. Senti will go public in $296M [...]
Forbion arms biotech to stop sudden cardiac death, leading $35M round to fund phase 2 trial of Armgo’s pipeline-in-a-product
Forbion arms biotech to stop sudden cardiac death, leading $35M [...]
Novartis suffers shock setback as Xolair successor fails phase 3
Novartis suffers shock setback as Xolair successor fails phase 3 [...]
Roche’s Spark unit blueprints $575M gene therapy manufacturing center in Philly
Roche’s Spark unit blueprints $575M gene therapy manufacturing center in [...]